These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30059069)

  • 1. [Gemistocytic astrocytomas].
    Matsko DE; Zrelov AA; Ulitin AY; Matsko MV; Skliar SS; Baksheeva AO; Imyanitov EN
    Arkh Patol; 2018; 80(4):27-38. PubMed ID: 30059069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
    Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas.
    Ohta T; Kim YH; Oh JE; Satomi K; Nonoguchi N; Keyvani K; Pierscianek D; Sure U; Mittelbronn M; Paulus W; Vital A; Yokoo H; McDonald K; Kleihues P; Nazaret N; Barbet F; Lachuer J; Ohgaki H
    J Neuropathol Exp Neurol; 2014 Oct; 73(10):908-15. PubMed ID: 25192052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
    Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
    J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas.
    Reis RM; Hara A; Kleihues P; Ohgaki H
    Acta Neuropathol; 2001 Nov; 102(5):422-5. PubMed ID: 11699553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemistocytic astrocytomas: a reappraisal.
    Krouwer HG; Davis RL; Silver P; Prados M
    J Neurosurg; 1991 Mar; 74(3):399-406. PubMed ID: 1993905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlation in gemistocytic astrocytomas.
    Kösel S; Scheithauer BW; Graeber MB
    Neurosurgery; 2001 Jan; 48(1):187-93; discussion 193-4. PubMed ID: 11152345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition and diagnostic implications of gemistocytic astrocytomas: a pathological perspective.
    Tihan T; Vohra P; Berger MS; Keles GE
    J Neurooncol; 2006 Jan; 76(2):175-83. PubMed ID: 16132490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers.
    Ichimura K; Narita Y; Hawkins CE
    Acta Neuropathol; 2015 Jun; 129(6):789-808. PubMed ID: 25975377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia in gemistocytic astrocytomas.
    Geranmayeh F; Scheithauer BW; Spitzer C; Meyer FB; Svensson-Engwall AC; Graeber MB
    Neurosurgery; 2007 Jan; 60(1):159-66; discussion 166. PubMed ID: 17228265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy Number Profiling of Brazilian Astrocytomas.
    Bidinotto LT; Torrieri R; Mackay A; Almeida GC; Viana-Pereira M; Cruvinel-Carloni A; Spina ML; Campanella NC; Pereira de Menezes W; Clara CA; Becker AP; Jones C; Reis RM
    G3 (Bethesda); 2016 Jul; 6(7):1867-78. PubMed ID: 27172220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.
    Ferris SP; Goode B; Joseph NM; Kline CN; Samuel D; Gupta N; Bollen A; Perry A; Mueller S; Solomon DA
    Acta Neuropathol; 2016 Jul; 132(1):153-5. PubMed ID: 27161253
    [No Abstract]   [Full Text] [Related]  

  • 14. Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigation.
    Mott RT; Turner KC; Bigner DD; McLendon RE
    J Neurosurg; 2008 Feb; 108(2):330-5. PubMed ID: 18240930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome.
    Motomura K; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nakazato Y; Tanaka Y; Pierscianek D; Kim YH; Mariani L; Vital A; Ohgaki H
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):702-7. PubMed ID: 22805772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
    Momota H; Narita Y; Matsushita Y; Miyakita Y; Shibui S
    Brain Tumor Pathol; 2010 Oct; 27(2):95-101. PubMed ID: 21046311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of high-grade astrocytoma.
    Sathornsumetee S; Rich JN; Reardon DA
    Neurol Clin; 2007 Nov; 25(4):1111-39, x. PubMed ID: 17964028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative transcriptomics reveals similarities and differences between astrocytoma grades.
    Seifert M; Garbe M; Friedrich B; Mittelbronn M; Klink B
    BMC Cancer; 2015 Dec; 15():952. PubMed ID: 26673168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.